title: PRC2 overexpression and PRC2-target gene repression relating to poorer prognosis in small cell lung cancer.
abstract: Small cell lung cancer (SCLC) is a subtype of lung cancer with poor prognosis. Expression array analysis of 23 SCLC cases and 42 normal tissues revealed that EZH2 and other PRC2 members were highly expressed in SCLC. ChIP-seq for H3K27me3 suggested that genes with H3K27me3(+) in SCLC were extended not only to PRC2-target genes in ES cells but also to other target genes such as cellular adhesion-related genes. These H3K27me3(+) genes in SCLC were repressed significantly, and introduction of the most repressed gene JUB into SCLC cell line lead to growth inhibition. Shorter overall survival of clinical SCLC cases correlated to repression of JUB alone, or a set of four genes including H3K27me3(+) genes. Treatment with EZH2 inhibitors, DZNep and GSK126, resulted in growth repression of SCLC cell lines. High PRC2 expression was suggested to contribute to gene repression in SCLC, and may play a role in genesis of SCLC.
authors.affiliation: Genome Science Division, Research Center for Advanced Science and Technology (RCAST), The University of Tokyo, Tokyo, Japan.
authors.forename: Teruyuki
authors.initials: T
authors.lastname: Sato
authors.forename: Atsushi
authors.initials: A
authors.lastname: Kaneda
authors.forename: Shingo
authors.initials: S
authors.lastname: Tsuji
authors.forename: Takayuki
authors.initials: T
authors.lastname: Isagawa
authors.forename: Shogo
authors.initials: S
authors.lastname: Yamamoto
authors.forename: Takanori
authors.initials: T
authors.lastname: Fujita
authors.forename: Ryota
authors.initials: R
authors.lastname: Yamanaka
authors.forename: Yukiko
authors.initials: Y
authors.lastname: Tanaka
authors.forename: Toshihiro
authors.initials: T
authors.lastname: Nukiwa
authors.forename: Victor E
authors.initials: VE
authors.lastname: Marquez
authors.forename: Yuichi
authors.initials: Y
authors.lastname: Ishikawa
authors.forename: Masakazu
authors.initials: M
authors.lastname: Ichinose
authors.forename: Hiroyuki
authors.initials: H
authors.lastname: Aburatani
mesh_terms: D014408:Biomarkers, Tumor / Q000235:genetics / Q000378:metabolism; D015153:Blotting, Western; D016022:Case-Control Studies; D049109:Cell Proliferation; D047369:Chromatin Immunoprecipitation; D000071221:Enhancer of Zeste Homolog 2 Protein; D005455:Fluorescent Antibody Technique; D020869:Gene Expression Profiling; D006657:Histones / Q000378:metabolism; D006801:Humans; D007211:Indoles / Q000494:pharmacology; D056484:Jumonji Domain-Containing Histone Demethylases; D060588:LIM Domain Proteins / Q000235:genetics / Q000378:metabolism*; D008168:Lung / Q000378:metabolism*; D008175:Lung Neoplasms / Q000235:genetics / Q000378:metabolism / Q000401:mortality*; D020411:Oligonucleotide Array Sequence Analysis; D063151:Polycomb Repressive Complex 2 / Q000037:antagonists & inhibitors / Q000235:genetics / Q000378:metabolism*; D011379:Prognosis; D011728:Pyridones / Q000494:pharmacology; D012333:RNA, Messenger / Q000235:genetics; D060888:Real-Time Polymerase Chain Reaction; D020133:Reverse Transcriptase Polymerase Chain Reaction; D055752:Small Cell Lung Carcinoma / Q000235:genetics / Q000378:metabolism / Q000401:mortality*; D015996:Survival Rate; D014407:Tumor Cells, Cultured
chemical_list: C485608:AJUBA protein, human; D014408:Biomarkers, Tumor; C577920:GSK-2816126; D006657:Histones; D007211:Indoles; D060588:LIM Domain Proteins; D011728:Pyridones; D012333:RNA, Messenger; D056484:Jumonji Domain-Containing Histone Demethylases; C523761:Kdm6b protein, mouse; C498409:EZH2 protein, human; D000071221:Enhancer of Zeste Homolog 2 Protein; D063151:Polycomb Repressive Complex 2